Peyer James's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Feb 16, 2022
- Accession no.
- 0001567619-22-004777
- Filed
- Feb 16, 2022
- Trade date
- Feb 14-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $52.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peyer JamesCIK 0001843594 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | PPurchaseAcquired | +10,000 | $4.18 | +$41,800 | 5,185,786 | Indirect | |
| Feb 16, 2022 | Common Stock | PPurchaseAcquired | +2,551 | $4.25 | +$10,841.75 | 5,188,337 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.